What is Passage Bio, Inc. Common Stock's Market Cap?

Passage Bio, Inc. Common Stock's Market Cap is $15.6M, based on as-reported figures from SEC (XBRL) filings.

What is Passage Bio, Inc. Common Stock's Enterprise Value?

Passage Bio, Inc. Common Stock's Enterprise Value is -$8.5M, based on as-reported figures from SEC (XBRL) filings.

What is Passage Bio, Inc. Common Stock's EV / EBITDA?

Passage Bio, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.

What is Passage Bio, Inc. Common Stock's Net Income (TTM)?

Passage Bio, Inc. Common Stock's Net Income (TTM) is -$36.1M, based on as-reported figures from SEC (XBRL) filings.

What is Passage Bio, Inc. Common Stock's EBITDA?

Passage Bio, Inc. Common Stock's EBITDA is -$38.5M, based on as-reported figures from SEC (XBRL) filings.

What is Passage Bio, Inc. Common Stock's Diluted EPS (TTM)?

Passage Bio, Inc. Common Stock's Diluted EPS (TTM) is -11.22, based on as-reported figures from SEC (XBRL) filings.

What is Passage Bio, Inc. Common Stock's Net Debt?

Passage Bio, Inc. Common Stock's Net Debt is -$24.2M, based on as-reported figures from SEC (XBRL) filings.

Passage Bio, Inc. Common Stock (PASG) Financial Statements

Passage Bio, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00NBK4XG8

XNAS · usd

4.85▲ 0.20 (4.30%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.65

Day's Range4.63 – 4.91

52-Week Range3.29 – 20.05

Volume14.6K

Avg Volume12.9K

Share Statistics

Shares Outstanding

Employees24

ExchangeXNAS

Listed2020-02-28

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Passage Bio, Inc. Common Stock (PASG)

What is Passage Bio, Inc. Common Stock's Market Cap?: Passage Bio, Inc. Common Stock's Market Cap is $15.6M, based on as-reported figures from SEC (XBRL) filings.
What is Passage Bio, Inc. Common Stock's Enterprise Value?: Passage Bio, Inc. Common Stock's Enterprise Value is -$8.5M, based on as-reported figures from SEC (XBRL) filings.
What is Passage Bio, Inc. Common Stock's EV / EBITDA?: Passage Bio, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Passage Bio, Inc. Common Stock's Net Income (TTM)?: Passage Bio, Inc. Common Stock's Net Income (TTM) is -$36.1M, based on as-reported figures from SEC (XBRL) filings.
What is Passage Bio, Inc. Common Stock's EBITDA?: Passage Bio, Inc. Common Stock's EBITDA is -$38.5M, based on as-reported figures from SEC (XBRL) filings.
What is Passage Bio, Inc. Common Stock's Diluted EPS (TTM)?: Passage Bio, Inc. Common Stock's Diluted EPS (TTM) is -11.22, based on as-reported figures from SEC (XBRL) filings.
What is Passage Bio, Inc. Common Stock's Net Debt?: Passage Bio, Inc. Common Stock's Net Debt is -$24.2M, based on as-reported figures from SEC (XBRL) filings.